CDK18/cyclin Y, active

active CDK18/cyclin Y. N-terminal GST-tagged, recombinant, human CDK18 full length and N-terminal GST-tagged, recombinant human cyclin Y full length.

Catalog #: 15-031


Biological Information
Background Information:
CDK18, cyclin dependent kinase 18, is predicted to enable ATP binding activity and to be involved in protein phosphorylation and regulation of transcription involved in G1/S transition of mitotic cell cycle. It may play a role in signal transduction cascades in terminally differentiated cells. [provided by Alliance of Genome Resources, Apr 2022]
Target Class:
Serine/Threonine Kinase: TAIRE subfamily
Accession Number:
NM_212502.1. The recombinant protein contains one residue which is in conflict with NM_212502.1. This is T166M and is reported in GenBank BC011526.1.
Target Name:
Target Aliases:
Cyclin Dependent Kinase 18, PCTAIRE3, PCTK3, Serine/Threonine-Protein Kinase PCTAIRE-3, PCTAIRE Protein Kinase 3
Target Species:
Product Type:
Drug Discovery & Development
Storage Conditions:
1 year at -70°C
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit for a list of products that are governed by limited use label license terms and relevant patent and trademark information.


15-031x Datasheet

View Document